NEWEarnings

Precigen (PGEN) Share Trading at $4.02 with P/E Ratio of 9.14

Published on 5/3/2026

#PGEN#earnings#biotech#revenue#P/E
Precigen (PGEN) Share Trading at $4.02 with P/E Ratio of 9.14

AI Summary

Precigen, Inc. (PGEN) shares were trading at $4.02 as of April 28, with a forward P/E ratio of 9.14. The company recently transitioned to a commercial rare disease platform, following the approval of Papzimeous for recurrent respiratory papillomatosis. Market modeling predicts that by 2026, approximately 1,600–1,700 patients could be treated, rising to nearly 3,000 in 2027, which may lead to significant revenue fluctuations. Projections suggest potential quarterly earnings surprises exceeding 100% to 300% in 2026, setting the stage for notable market interest.

Source: Read original article (opens in new tab)

Related News

VRSK Stock at $188.19 with P/E Ratios 27.26 and 23.31
Earnings

VRSK Stock at $188.19 with P/E Ratios 27.26 and 23.31

May 3

Vestis Corporation (VSTS) Trading at $9.57, P/E Ratio 17.49
Earnings

Vestis Corporation (VSTS) Trading at $9.57, P/E Ratio 17.49

May 3

Cactus, Inc. (WHD) P/E Ratios at 23.20 and 48.08, Shares at $55.77
M&A

Cactus, Inc. (WHD) P/E Ratios at 23.20 and 48.08, Shares at $55.77

May 3

ON (ON) Stock Trading at $93.30 with P/E Ratios of 338.07 and 33.78
Tech

ON (ON) Stock Trading at $93.30 with P/E Ratios of 338.07 and 33.78

May 3